ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the material weaknesses in SoundHound's internal controls over financial reporting impaired the Company's ability to effectively account for corporate acquisitions; (ii) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material weaknesses in its internal controls over financial repor ...

CLASS PERIOD: This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Ibotta securities pursuant and/or traceable to documents issued in connection with Ibotta's April 18, 2024 initial public offering. ALLEGATIONS: According to the filed complaint, defendants made false statements and/or concealed that they did not properly warn investors of the risks concerning Ibotta's contract with The Kroger Co. ("Kroger"). Kroger's contract was at-will, and Ibotta failed to ...

Core Viewpoint - The Gross Law Firm has initiated a class action lawsuit on behalf of shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV) due to alleged misleading statements and omissions related to a secondary stock offering and subsequent merger with AbbVie Inc. [1][2] Group 1: Allegations and Impact - Cerevel's October 16, 2023 secondary stock offering documents allegedly omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share, which artificially deflated Cerevel's stock price until the merger announcement [2] - Bain Capital, Cerevel's controlling shareholder, reportedly acquired shares at the depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall exceeding $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [2] - Cerevel's January 18, 2024 Proxy statement is claimed to have misled investors regarding the nature and timing of AbbVie's interest in the company [2] Group 2: Class Action Details - The class period for the lawsuit includes shareholders who sold or disposed of Cerevel stock from October 11, 2023, to August 1, 2024, and those who held shares as of January 8, 2024, entitled to vote on the merger [1][2] - The deadline for shareholders to register for the class action and seek lead plaintiff status is June 3, 2025, with no cost or obligation to participate [3]

Core Viewpoint - Fluence Energy, Inc. is facing allegations of issuing materially false and misleading statements regarding its business operations and financial performance during the class period from October 28, 2021, to February 10, 2025 [1] Allegations - The complaint claims that Fluence's relationship with its founders and major revenue sources, Siemens AG and The AES Corporation, was expected to decline [1] - Siemens Energy, the U.S. affiliate of Siemens AG, accused Fluence of engineering failures and fraud [1] - Fluence's reported margins and revenue growth were allegedly inflated as Siemens and AES were moving towards divestment [1] - Due to the aforementioned issues, the defendants reportedly lacked a reasonable basis for their positive statements regarding Fluence's battery energy storage business and its financial results, growth, and prospects [1] Class Action Details - Shareholders who purchased FLNC shares during the specified class period are encouraged to register for the class action by May 12, 2025 [2] - Registered shareholders will be enrolled in a portfolio monitoring system to receive updates throughout the case [2] - There is no cost or obligation for shareholders to participate in the case [2]

NEW YORK, May 8, 2025 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA).Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/ibotta-loss-submission-form/?id=147318&from=4CLASS PERIOD: This lawsuit is on behalf of persons o ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which may have artificially deflated the stock price prior to a merger announcement with AbbVie Inc. [1][4] Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes shareholders who sold or held shares during this timeframe [3]. - Shareholders are encouraged to register for the class action by June 3, 2025, to potentially be appointed as lead plaintiffs [5]. Group 2: Allegations Against Cerevel - The complaint alleges that Cerevel's October 16, 2023, secondary stock offering documents omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share [4]. - Bain Capital, Cerevel's controlling shareholder, allegedly acquired shares at an artificially depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [4]. Group 3: Next Steps for Shareholders - Shareholders who register will be enrolled in a portfolio monitoring software to receive updates on the case's status [5]. - There is no cost or obligation for shareholders to participate in the class action [5].

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA). Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ibotta-loss-submission-form/?id=147115&from=3 CLASS PERIOD: This lawsuit is on behalf of ...

Core Viewpoint - Fluence Energy, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its business relationships and financial performance during the class period from October 28, 2021, to February 10, 2025 [3]. Summary by Relevant Sections - **Class Period and Allegations** - The class period for the lawsuit is defined as October 28, 2021, to February 10, 2025 [3]. - Allegations include that Fluence's relationships with key partners, Siemens AG and The AES Corporation, were expected to decline, and that Siemens Energy accused Fluence of engineering failures and fraud [3]. - It is claimed that Fluence's reported margins and revenue growth were inflated as Siemens and AES were moving to divest, leading to a lack of reasonable basis for positive statements regarding Fluence's battery energy storage business and financial prospects [3]. - **Next Steps for Shareholders** - Shareholders who purchased FLNC shares during the specified timeframe are encouraged to register for the class action by May 12, 2025, to potentially become lead plaintiffs [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [4]. - **Law Firm Background** - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [5].

NEW YORK, May 5, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA).Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/ibotta-loss-submission-form/?id=146610&from=4CLASS PERIOD: This lawsuit is on behalf of persons ...

NEW YORK, May 5, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Solaris Energy Infrastructure, Inc. (NYSE: SEI).Shareholders who purchased shares of SEI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/solaris-energy-infrastructure-inc-loss-submission-form/?id=146603&from=4CLA ...